Previous Article | Next Article 
Applied and Environmental Microbiology, October 2000, p. 4449-4455, Vol. 66, No. 10
Department of
Entomology1 and Interdepartmental
Graduate Programs in Genetics2 and
Microbiology,3 University of
California, Riverside, Riverside, California 92521
Received 18 April 2000/Accepted 13 July 2000
Cry1 protoxins of Bacillus thuringiensis
are insecticidal 135-kDa proteins synthesized and assembled into
parasporal crystals during sporulation. After ingestion, these crystals
dissolve in the midgut and active toxins with molecular masses of about
65-kDa are released from the N-terminal half of the molecule by midgut proteases. Direct synthesis of the toxin-containing N-terminal half of
Cry1 molecules using recombinant DNA techniques results in a low level
of unstable truncated proteins that do not crystallize. In the present
study, inclusions of truncated Cry1C (Cry1C-t) were obtained by
combining genetic elements from other endotoxin genes and
operons that enhance Cry protein synthesis and crystallization. Increased levels of Cry1C-t synthesis were achieved by using
cyt1A promoters to drive expression of the 5' half of
cry1C that included in the construct the 5'
cry3A STAB-SD mRNA stabilizing sequence and the 3'
stem-loop transcription terminator. RNA dot blot analysis showed that
the STAB-SD and 3' transcriptional termination sequences were important
for stabilization of truncated cry1C (cry1C-t) mRNA. A low level of cry1C-t mRNA was present when only the
cyt1A promoters were used to express cry1C-t,
but no accumulation of Cry1C-t was detected in Western blots. The
orientation of the transcription terminator was important to enhancing
Cry1C-t synthesis. Inclusion of the 20- and 29-kDa helper protein genes
in cry1C-t constructs further enhanced synthesis. The
Cry1C-t protein was toxic to Spodoptera exigua larvae,
though the toxicity (50% lethal concentration [LC50] = 13.2 µg/ml) was lower than that of full-length Cry1C
(LC50 = 1.8 µg/ml). However, transformation of the
HD1 isolate of B. thuringiensis subsp.
kurstaki with the cry1C-t construct enhanced its toxicity to S. exigua as much as fourfold.
Insecticidal Cry proteins
produced by Bacillus thuringiensis are
the principal active ingredients of most bacterial insecticides. Based
on mass, there are two major types of Cry proteins, those with
molecular masses of approximately 135 kDa, such as the common Cry1
protoxins, and those with molecular masses of approximately 70 kDa, exemplified by Cry2A, Cry3A, and Cry11A (16). The
amino acid sequence of the latter type corresponds to the amino acid sequence of the N-terminal half of the former type. Cry proteins typically are synthesized as protoxins during sporulation and are
assembled into crystals that stabilize the toxin (3, 8). When ingested by insects, the crystals dissolve in the midgut and the
protoxin is cleaved by midgut proteases, releasing an active
polypeptide with a molecular mass of 65 to 68 kDa (1, 16,
17).
Because the C-terminal half of 135-kDa Cry1 protoxins is not toxic, if
it could be eliminated and the cellular resources could be redirected
to synthesize an equivalent additional amount of the N-terminal half,
the specific toxicity Several genetic elements that enhance synthesis and crystallization of
"naturally truncated" Cry toxins, such as Cry2A, Cry3A, and Cry11A,
have been identified recently. These elements include the 5'
STAB-SD mRNA stabilizing sequence of cry3A
(2), 3' stem-loop structures that also stabilize
cry transcripts (24), and two helper proteins
that enhance translation and/or crystallization. These two helper
proteins are the 20-kDa chaperone-like protein encoded by
orf3 of the cry11A operon (6, 25,
26) and the 29-kDa protein encoded by orf2 of the
cry2A operon (23), which apparently
serves both as a molecular chaperone (5) and a scaffolding protein that facilitates Cry2A crystal formation (7).
Several studies have shown that these elements, alone or in combination
with each other or other genetic elements, can be manipulated to
enhance Cry synthesis. For example, Park et al. (13)
demonstrated that Cry3A synthesis could be increased more than 10-fold
in comparison to the synthesis by the wild-type strain by driving
expression of cry3A, including the STAB-SD sequence, with strong cyt1A promoters. In another study, synthesis of
Cry2A and Cry11A using the cyt1A promoters-STAB-SD
expression system resulted in more moderate but still significant
increases of 4.4- and 1.3-fold, respectively (14). With
respect to the helper proteins, the 20-kDa protein enhances net
synthesis of Cry2A (7).
In the present study, we made various combinations of these enhancer
elements and evaluated them to determine their capacities to enhance
the synthesis and crystallization of truncated Cry1C (Cry1C-t)
molecules. Here we show that inclusions of Cry1C-t can be produced by
combining mRNA stabilizing sequences and helper protein genes
in constructs containing truncated cry1C
(cry1C-t). We also show that adding this construct to a
wild-type strain of B. thuringiensis improves
its insecticidal activity against the beet armyworm, Spodoptera
exigua, an important insect pest.
Bacterial strains and transformation.
Plasmid constructs
were amplified in Escherichia coli DH5 PCR.
The PCR was performed by using the Expand Long Template
PCR system (Boehringer, Mannheim, Germany) or with Vent
(Exo+) DNA polymerase (New England Biolabs).
Construction of cry1C-t.
The plasmid constructs used
are shown in Fig. 1 and Table
1, and the primers used for gene
amplification are listed in Table 2.
Plasmid p2-44, which contained the intact cry1C gene
(GenBank accession number X96682), was provided by Abbott Laboratories (North Chicago, Ill.). The cry1C gene was obtained as a
4.8-kb EcoRI-HindIII fragment from p2-44,
filled with the Klenow fragment, and cloned into the SmaI
site of pHT3101 (11) to generate pPF1C. The cry1C
open reading frame (ORF) in pPF1C was amplified with primers 1Ca-1 and
1Ca-3 (Table 2) by using a DNA thermal cycler (Perkin Elmer GeneAmp PCR
system 2400) and inserted into expression vector pPF-CH that contained
the cyt1A promoters and STAB-SD sequence to generate
pPFT1Cs. The cry1C-t fragment was amplified with primers 1Ca-1 and 1Ca-2 and inserted into pHTCytA (13), which
contained cyt1A promoters, to generate pPFT1C-t or into
pHTCytA with STAB-SD (pPF-CH) to generate pPFT1Cs-t. The
cry1C-t gene encodes 630 amino acids, and the C-terminal
amino acid is K630. The 479-bp fragment containing the
transcription termination sequence (TTS) in pPFT3As (13) was
obtained by PCR using primers 3Aa-1 and 3Aa-2. The 479-bp fragment was
digested with SphI and cloned into the same site in
pPFT1Cs-t to generate pPFT1Cs-t3(+), with the TTS in the same
orientation as the cry1C ORF, and pPFT1Cs-3t(
0099-2240/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Molecular Genetic Manipulation of Truncated Cry1C Protein
Synthesis in Bacillus thuringiensis To Improve
Stability and Yield
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
i.e., the toxicity per unit of mass of bacterial
insecticidesmight be improved. This would in essence convert Cry1
proteins by truncation into toxins like Cry2A or Cry3A. When truncated
cry1 genes are expressed in B. thuringiensis, however, the toxin yields are low, and
the truncated proteins do not form inclusions (1, 15, 22). Possible reasons for this include a low level of truncated gene expression, instability of the truncated mRNA and protein, and inefficient crystallization of the truncated protein.
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
. The
cry1C constructs were expressed in an acrystalliferous
strain of B. thuringiensis subsp.
israelensis (4Q7), B. thuringiensis subsp. kurstaki HD-1, or B. thuringiensis subsp. aizawai 1857. The
B. thuringiensis strains were transformed by
electroporation as previously described (13).
), with the
TTS in the orientation opposite that of the cry1C ORF. The
1.5-kb fragment in pPFT11Ast containing the 20-kDa gene was amplified
with primers 11Aa-1 and 11Aa-2 and inserted into the SphI
site of pPFT1Cs-t to generate pPFT1Cs-20k. The 850-bp fragment in
pPFT2Asf containing orf2 of the cry2A
operon was amplified with primers 2Aa-1 and 2Aa-2 and inserted
into the XbaI-SalI site of pPF-CH to generate
pPF-ORF2. The 2.38- and 3.41-kb SalI-SphI fragments were obtained from pPFT1Cs-3t(+) and pPFT1Cs-20k,
respectively, and were inserted into the
SalI-SphI site of pPF-ORF2 to generate pPFT1Csf-3t(+) and pPFT1Csf-20k.
View larger version (43K):
[in a new window]
FIG. 1.
Summary of vector construction for expression
of full-length and truncated cry1C genes. (A) The vectors
pPFT3As and pPF1C were used as templates for further construction. The
full-length cry1C gene, including its promoter region, was
obtained as a 4.8-kb fragment of plasmid 2-44 (see Materials and
Methods) partially digested with EcoRI and
HindIII. This fragment was treated with the Klenow
fragment and inserted into pHT3101 to generate pPF1C. (B) The
full-length and truncated cry1C ORFs beginning at the ATG
codon were inserted into the SalI-SphI sites and
SalI sites of pPF-CH (see Materials and Methods) to generate
pPFT1Cs and pPFT1Cs-t, respectively. For cry1C-t without the
STAB-SD sequence, the same fragment used for construction of
pPFT1Cs-t was inserted into SalI sites of pHTCytA. To add
the 3' TTS to truncated cry1C-t, a 479-bp cry3A
termination sequence was inserted into the SphI site of
pPFT1Cs-t [pPFT1Cs-3t(+) and pPFT1Cs-3t( )]. (C) The vectors
pPFT2Asf and pPFT11Ast were used as templates for amplification of
orf2 and the 20-kDa protein gene. (D) For the 20-kDa
protein, a 1.5-kb fragment from pPFT11Ast was inserted into the
SphI site of pPFT1Cs-t (pPFT1Cs-20k). For the ORF2 protein
gene, a 850-bp fragment from pPFT2Asf was inserted into the
XbaI-SalI site of pPF-CH (pPF-ORF2). Then 2.38- and 3.41-kb fragments, obtained from SalI-SphI
partial digestion of pPFT1Cs-3t(+) and pPFT1Cs-20k, respectively, were
inserted into the SalI-SphI site of pPF-ORF2 to
generate pPFT1Csf-3t(+) and pPFT1Csf-20k.
TABLE 1.
Summary of genetic elements present in each
cry1C construct
TABLE 2.
Primers used to amplify cry1C,
cry2A, cry3A, and
cry11A sequences
cry1C-specific antisense probe. A 0.8-kb cry1C-specific antisense DNA probe was made by unidirectional PCR using digoxigenin-labeled nucleotides (Boehringer) and the 1Ca-2 primer. The truncated cry1C-t gene PCR product was used as the substrate for Vent (Exo+) DNA polymerase (New England Biolabs).
RNA isolation and dot blot analysis. RNA was isolated from sporulating cells grown in 10 ml of nutrient broth plus salts (NBG) at 30°C for 12 h (14). The bacterial cells were centrifuged at 6,000 × g for 5 min at 4°C, and the pellets were suspended in 1 ml of TRIzol reagent (GIBCO BRL, Grand Island, N.Y.). Sodium dodecyl sulfate (SDS) was added to a final concentration of 1% (vol/vol). The suspension was sonicated 10 times on ice at 50% duty cycle for 15 s (Ultrasonic Homogenizer 4710 series; Cole-Parmer Instrument Co., Chicago, Ill.). After samples were incubated at room temperature for 5 min, 200 µl of chloroform was added. The samples were mixed thoroughly and centrifuged at 12,000 × g for 15 min. The aqueous phase was transferred to a fresh tube, and 500 µl of isopropanol was added. After incubation at room temperature for 10 min, RNA was collected by centrifugation at 12,000 × g for 10 min. The RNA pellets were washed with 1 ml of 75% ethanol, spun at 7,500 × g for 5 min, dried, and dissolved in 50 µl of diethyl pyrocarbonate-treated double-distilled water. RNA concentrations were determined by measuring the absorption at 260 nm with a PM6 spectrophotometer (Zeiss, Oberkochen, Germany). RNA samples (1 and 2.5 µg) were spotted on a nylon membrane (Micron Separations, Inc., Westborough, Mass.). The membrane was dried in a vacuum oven at 80°C for 2 h. Prehybridization and hybridization at 42°C with the antisense-cry1C DNA probe and detection with the CDP-Star reagent (Boehringer) were performed according to the manufacturer's protocol. After exposure, the detection film was scanned with the GAS 4000 gel documentation system (Evergreen). The level of hybridization was quantified by using ImageQuant 4.1 densitometry software (Molecular Dynamics, Sunnyvale, Calif.). Hybridization values were determined by comparison to the signal obtained with reference plasmid pPFT1C-t, which was assigned a value of 1. RNA dot blots were replicated three times by using three different RNA preparations from three different cultures. Data from the blots were analyzed with the Super ANOVA program (Abacus Concepts, Berkeley, Calif.) (13, 14).
SDS-PAGE. Bacterial strains were grown in 50 ml of NBG (14) at 30°C for 5 days, by which time the cells had sporulated and lysed. Spores, crystals, and cell debris were pelleted in 1.2-ml aliquots by centrifugation at 15,000 × g for 1 min. The pellets were suspended in 50 µl of 5× sample buffer (10) and boiled for 5 min. After centrifugation at 15,000 × g for 5 min to remove solids, 10-µl samples were loaded onto a 12% polyacrylamide gel and the proteins were separated by electrophoresis. Samples taken from three sets of cultures grown on different days were analyzed by SDS-polyacrylamide gel electrophoresis (PAGE), and the gels were scanned and quantified with the Super ANOVA program (Abacus Concepts) (13, 14).
Purification of Cry1C inclusions. Sporulated cells were pelleted by centrifugation at 6,500 × g for 15 min, suspended in 15 ml of distilled water, and sonicated twice at 50% duty cycle for 15 s by using the Ultrasonic Homogenizer 4710. Five-milliliter samples were loaded onto a discontinuous NaBr gradient (9), which was then centrifuged at 20,000 × g for 45 min at 10°C in a Beckman L7-55 ultracentrifuge. Bands containing inclusions were collected and dialyzed in water overnight at 4°C. Purified inclusions were pelleted and lyophilized.
Western blot analysis. Protein concentrations were determined by the method of Bradford (4). Proteins in 5- or 10-µg samples were separated by electrophoresis in an SDS-10% polyacrylamide gel and electroblotted onto a polyvinylidene difluoride membrane (Micron Separations, Inc.) by using a model PS50 electroblotter (Hoefer Scientific Instruments). Western blot analysis was performed by using primary rabbit anti-Cry1C antibody kindly provided by W. J. Moar (Department of Entomology, Auburn University, Auburn, Ala.) and alkaline phosphatase-conjugated goat anti-rabbit immunoglobulin G (Southern Biotechnology Associates, Inc., Birmingham, Ala.) as the secondary antibody (20). Binding of the secondary antibody was detected with the nitroblue tetrazolium and 5-bromo-1-chloro-3-indolyl phosphate (BCIP) reagents (Promega, Madison, Wis.).
Microscopy. Sporulating cultures were monitored and photographed with a DMRE phase-contrast microscope (Leica) at a magnification of ×1,000.
Bioassays. Bioassays with neonate S. exigua larvae were carried out as previously described (12). The assays were performed in 24-well plates (Corning) by using lyophilized powder preparations containing spores and crystal inclusions mixed in artificial diet, as described by Moar et al. (12). Two larvae were placed in each well and then held at 28°C under a daily regime consisting of 16 h of light and 8 h of darkness. A total of 48 larvae were used for each protein concentration assayed. Larval mortality was determined after 7 days of exposure to the spore-crystal toxin mixture; larvae were considered to be alive if they were able to respond to tactile stimulation.
| |
RESULTS |
|---|
|
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
|
|---|
Expression of cry1C-t.
When cry1C-t was
expressed using pPFT1C-t (Fig. 1), which contained cyt1A
promoters to drive expression but lacked the STAB-SD and
cry3A 3' stem-loop sequences, the transcript level as
determined by RNA dot blots was low (Fig.
2, lane 1). Inclusion of STAB-SD in
the construct (pPFT1Cs-t) yielded a twofold increase in the level of
cry1C-t transcript detected (Fig. 2, lane 2). When both STAB-SD and the 3' stem-loop were included in the construct
[pPFT1Cs-3t(+)], the transcript level increased to 2.6 times that
of the construct which lacked these elements, pPFT1C-t (Fig. 1; Fig. 2,
lane 3; Table 1). Placement of the cry3A stem-loop in the
orientation opposite that of cry1C-t [pPFT1Cs-3t()]
(Fig. 1; Table 1) resulted in a marked reduction in the level of
transcript detected (Fig. 2, lane 4).
|
Synthesis of Cry1C-t and inclusion formation.
Constructs which
lacked the STAB-SD and cry3A 3' stem-loop sequences
(pPFT1C-t) (Fig. 1) or contained the STAB-SD sequence and
cry3A stem-loop in the orientation opposite that of
cry1C-t [pPFT1Cs-3t()] produced little or no detectable
Cry1C-t 68-kDa protein as determined by Western blot analysis (Fig. 3A
and B, lanes 1 and 4). No Cry1C-t
inclusions were observed in strains transformed with these constructs
(Fig. 4A). However, when various elements
that stabilized the transcript or enhanced net protein synthesis were
included in the constructs, substantial increases in Cry1C-t levels
were obtained, and inclusions of this protein were observed (Fig. 3A
and B, lanes 2, 3, 5, 6, and 7, and 4B and C). For example, when the
STAB-SD sequence was included in pPFT1C-t (pPFT1Cs-t) (Fig. 1;
Table 1) or the cry3A stem-loop sequence, placed in the same
orientation as cry1C-t, was included in pPFT1Cs-t
[pPFT1Cs-3t(+)] (Fig. 1; Table 1), the constructs produced Cry1C-t
(Fig. 3A and B, lanes 2 and 3). Comparable levels of Cry1C-t were also
detected with constructs that contained the 29- or 20-kDa protein genes
(Fig. 3A and B, lanes 5 and 6), though inclusions were observed in only
about 33% of the sporulating cells (data not shown). The sizes of
these inclusions were similar to those in cells with pPFT1Cs-3t(+). The
inclusions produced by the construct containing both the 20- and 29-kDa
protein genes (pPFT1Csf-20k) (Fig. 1; Table 1) appeared to be larger
than those produced by the other constructs (Fig. 4C). In most cells,
two separate inclusions were observed in each cell when the constructs contained either the 20-kDa (pPFT1Cs-20k), 29-kDa [pPFT1Csf-3t(+)], or 20- and 29-kDa (pPFT1Csf-20k) protein genes (Fig. 4C).
|
|
|
Toxicity of Cry1C-t.
The results of bioassays performed with
neonate S. exigua larvae are shown in Tables
3 and 4.
Two constructs that had the highest levels of Cry1C-t synthesis were
compared with the construct containing full-length cry1C by
using B. thuringiensis subsp. israelensis 4Q7 as the host strain in each case (Table 3).
Neither Cry1C-t construct was nearly as toxic as the full-length
molecule. The 50% lethal concentrations (LC50s) for
pPFT1Cs-3t(+), which contained the STAB-SD and
cry3A stem-loop sequences in the same orientation
as cry1C-t, and pPFT1Csf-20k, which contained
STAB-SD plus the 29- and 20-kDa protein genes, were 23.4 and 13.2 µg/ml, respectively, whereas pPF1C, which included the
cry1C promoter to drive full-length cry1C, was
significantly more toxic (LC50 = 1.9 µg/ml).
|
|
| |
DISCUSSION |
|---|
|
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
|
|---|
cry1C-t was expressed in this study by using the cyt1A promoter-STAB-SD system (13) in combination with various other genetic elements shown previously to enhance Cry protein synthesis. These included the cry3A transcription terminator (18) and the 20- and 29-kDa so-called helper proteins that improve net synthesis and crystallization. The highest yield of Cry1C-t was obtained with a construct that included the 5' STAB-SD sequence, the 3' stem-loop structure, and genes encoding the 20- and 29-kDa helper proteins. Synthesis of Cry1C-t with this construct also resulted in inclusions of Cry1C-t crystals that were 50 to 80% the size of crystals formed by the full-length molecule. These results suggest that use of these enhancer elements in a single expression system might be useful for improving the synthesis of other truncated Cry1 proteins.
Previously, it was shown that the cry1Aa transcription
terminator in either orientation at the distal end of the penicillinase (penP) gene or interleukin (IL-2) gene increased
the half-life of their mRNAs by 2 to 6 min in Bacillus
subtilis and Escherichia coli (24).
This resulted in a concomitant increase in PenP and IL-2 synthesis. In
contrast to this, in the present study a marked decrease in
cry1C-t mRNA resulted when the orientation of the terminator was reversed (Fig. 2). This suggests that variations in
cry transcription terminators may be one of the
factors that determine the level of Cry synthesis. For example,
Cry1C-t inclusions were not obtained with pPFT1C-t
and pPFT1Cs-3t(), constructs which lacked the stem-loop
structure and contained the stem-loop structure in a 3'-5' orientation
rather than a 5'-3' orientation, respectively. Alternatively, Cry1C-t
inclusions were obtained with all constructs containing the stem-loop
in the same orientation as it occurs naturally in cry3A
(18). The lack of synthesis detected when the stem-loop was
in the 3'-5' orientation may have been due to instability of the transcript.
The potential role of the cry11A operon 20-kDa and cry2A operon 29-kDa proteins on the level of synthesis and crystallization of truncated Cry1 proteins has received only limited study. Rang et al. (15) showed that the 20-kDa protein increased net synthesis of Cry1C with deletions in the N-terminal half of the molecule but the proteins contained the C-terminal half of the molecule. Nevertheless, crystalline inclusions of these truncated proteins were not obtained. Similarly, the 20-kDa protein increased net synthesis of Cry2A but did not directly enhance crystallization of this toxin in the absence of the 29-kDa protein (7). In the present study, we showed that when the 20- and 29-kDa protein genes were used independently, though the cry1C-t transcript levels were lower than the levels obtained when these genes were absent (Fig. 2), similar levels of Cry1C-t were produced (Fig. 3). This suggests that the 20- and 29-kDa proteins play no role in cry1C-t expression or mRNA stability but function to enhance net synthesis of Cry1C-t.
The highest transcript level was obtained when both the 20- and 29-kDa protein genes were included in the construct. Thus, it appears that during transcription, cry1C-t was protected from 5'-3' and 3'-5' exoribonuclease attack by STAB-SD-29-kDa protein and/or the 20-kDa protein gene fragments that contained 5' and 3' stem-loop structures. It is likely that the increase in transcript stability contributed directly to the net increase in the yield of Cry1C-t in cells with pPFT1Csf-20k by about 21% (Fig. 3, lane 7). Moreover, the presence of large inclusions of Cry1C-t synthesized in cells with constructs containing the 20- and 29-kDa protein genes provides further evidence that the helper proteins which these genes encode can function as molecular chaperones, promoting inclusion formation by Cry proteins other than Cry11A and Cry2A.
In previous studies it has been shown that truncated versions of Cry1 proteins are unstable and have little or no toxicity compared to the toxicity of full-length toxins (1, 15, 19, 21). The instability is probably due to the inability of these proteins to fold and crystallize properly. For example, whereas the 20-kDa protein increased net synthesis of truncated Cry1C with deletions in the N-terminal half, no crystalline inclusion were observed (15). This suggests that residues in the N-terminal half of the molecule are essential for crystal formation. Here it is shown that Cry1C-t, which lacked the entire C terminus, was able to form crystalline inclusions, even though these inclusions were approximately 50 to 80% the size of those produced by wild-type Cry1C. In addition, the SDS-PAGE and Western blot data (Fig. 3) showed that Cry1C-t is unstable and is degraded to smaller peptides with molecular masses ranging from 55 to 58 kDa. There was a difference between the molecular mass of Cry1C-t molecules contained in purified crystalline inclusions (68 kDa) and the molecular masses of molecules in the spore-crystal mixture (55 to 58 kDa). This probably resulted from degradation of the 68-kDa Cry1C-t molecules that were not occluded in the inclusions, as these would have been exposed to proteases upon cell lysis (Fig. 5). The smaller 38-kDa peptides (Fig. 5), which were degraded to 31-kDa peptides (Fig. 3B), were possibly the translation products resulting from a second in-frame ATG codon, as noted previously (19).
It has been reported previously that Cry1C-t inclusions produced in E. coli were toxic to Spodoptera littoralis (19). However, this report contained no data on the relative toxicity of Cry1C-t or full-length Cry1C molecules to S. littoralis. The sequence of the Cry1C-t used in the present study was identical to the sequence of the Cry1C-t described previously (19). Here, it is shown that Cry1C-t produced in B. thuringiensis is also toxic to larvae of the beet armyworm, S. exigua, although the toxicity of the truncated protein was 7- to 12.6-fold less than that of the full-length Cry1C (Table 3). The reasons for the lower toxicity of the truncated form are not known at present, but the difference could be due to lower stability and perhaps incorrect folding in the absence of the large C terminus. Despite the lower toxicity of Cry1C-t, synthesis of this molecule in the HD1 isolate of B. thuringiensis subsp. kurstaki, the isolate used in the commercial insecticide Dipel, which lacks Cry1C, increased toxicity to S. exigua as much as fivefold (Table 4). This indicates that the N-terminal half of Cry1C was synthesized effectively in this strain, a finding that may increase this strain's commercial utility. A similar result was not observed with B. thuringiensis subsp. aizawai (Table 3), most likely because this strain already contains Cry1C.
| |
ACKNOWLEDGMENTS |
|---|
We thank Jeffrey J. Johnson for assistance during the course of this study.
This research was supported in part by grant 96-51 to B.A.F. from the University of California BioSTAR Program.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Entomology, University of California, Riverside, CA 92521. Phone: (909) 787-5006. Fax: (909) 787-3086. E-mail: brian.federici{at}ucr.edu.
| |
REFERENCES |
|---|
|
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
|
|---|
| 1. | Adang, M. J., M. J. Staver, T. A. Rocheleau, J. Leighton, R. F. Barker, and D. V. Thompson. 1985. Characterized full-length and truncated plasmid clones of the crystal protein of Bacillus thuringiensis subsp. kurstaki HD-73 and their toxicity to Manduca sexta. Gene 36:289-300[CrossRef][Medline]. |
| 2. | Agaisse, H., and D. Lereclus. 1996. STAB-SD: a Shine-Dalgarno sequence in the 5' untranslated region is a determinant of mRNA stability. Mol. Microbiol. 20:633-643[CrossRef][Medline]. |
| 3. | Baum, J. A., and T. Malvar. 1995. Regulation of insecticidal crystal protein production in Bacillus thuringiensis. Mol. Microbiol. 19:1-12. |
| 4. | Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254[CrossRef][Medline]. |
| 5. | Crickmore, N., and D. J. Ellar. 1992. Involvement of a possible chaperonin in the efficient expression of a cloned CryIIA delta-endotoxin gene in Bacillus thuringiensis. Mol. Microbiol. 6:1533-1537[CrossRef][Medline]. |
| 6. |
Dervyn, E.,
A. Poncet,
A. Klier, and G. Rapoport.
1995.
Transcriptional regulation of the cryIVD gene operon from Bacillus thuringiensis subsp. israelensis.
J. Bacteriol.
177:2283-2291 |
| 7. | Ge, B., D. Bideshi, W. J. Moar, and B. A. Federici. 1998. Differential effects of helper proteins encoded by the cry2A and cry11A operon on the formation of Cry2A inclusions in Bacillus thuringiensis. FEMS Microbiol. Lett. 165:35-41[CrossRef][Medline]. |
| 8. |
Hofte, H., and H. R. Whiteley.
1989.
Insecticidal crystal proteins of Bacillus thuringiensis.
Microbiol. Rev.
53:242-255 |
| 9. |
Ibarra, J. E., and B. A. Federici.
1986.
Isolation of a relatively nontoxic 65-kilodalton protein inclusion from the parasporal body of Bacillus thuringiensis subsp. israelensis.
J. Bacteriol.
165:527-533 |
| 10. | Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685[CrossRef][Medline]. |
| 11. |
Lereclus, D.,
O. Arantes,
J. Chaufaux, and M. Lecadet.
1989.
Transformation and expression of a cloned  -endotoxin gene in Bacillus thuringiensis.
FEMS Microbiol. Lett.
60:211-218[CrossRef].
|
| 12. | Moar, W. J., J. T. Trumble, and B. A. Federici. 1989. Comparative toxicity of spores and crystals from the NRD-12 and HD-1 strains of Bacillus thuringiensis subsp. kurstaki to neonate beet armyworm (Lepidoptera: Noctuidae). J. Econ. Entomol. 82:1593-1603. |
| 13. |
Park, H. W.,
B. Ge,
L. S. Bauer, and B. A. Federici.
1998.
Optimization of Cry3A yields in Bacillus thuringiensis by use of sporulation-dependent promoters in combination with the STAB-SD mRNA sequence.
Appl. Environ. Microbiol.
64:3932-3938 |
| 14. | Park, H. W., D. K. Bideshi, J. J. Johnson, and B. A. Federici. 1999. Differential enhancement of Cry2A versus Cry11A yields in Bacillus thuringiensis by use of the cry3A STAB mRNA sequence. FEMS Microbiol. Lett. 181:319-327[CrossRef][Medline]. |
| 15. | Rang, C., M. Bes, V. Lullien-Pellerin, D. Wu, B. A. Federici, and R. Frutos. 1996. Influence of the 20-kDa protein from Bacillus thuringiensis ssp. israelensis on the rate of production of truncated Cry1C proteins. FEMS Microbiol. Lett. 141:261-264[CrossRef][Medline]. |
| 16. |
Schnepf, E.,
N. Crickmore,
J. Van Rie,
D. Lereclus,
J. Baum,
J. Feitelson,
D. R. Zeigler, and D. H. Dean.
1998.
Bacillus thuringiensis and its pesticidal crystal proteins.
Microbiol. Mol. Biol. Rev.
62:775-806 |
| 17. |
Schnepf, H. E., and H. R. Whiteley.
1985.
Delineation of a toxin-encoding segment of a Bacillus thuringiensis crystal protein gene.
J. Biol. Chem.
260:6273-6280 |
| 18. |
Sekar, V.,
D. V. Thompson,
M. J. Maroney,
R. G. Bookland, and M. J. Adang.
1987.
Molecular cloning and characterization of the insecticidal crystal protein gene of Bacillus thuringiensis var. tenebrionis.
Proc. Natl. Acad. Sci. USA
84:7036-7040 |
| 19. | Strizhov, N., M. Keller, Z. Konez-Kalman, A. Regev, B. Sneh, J. Schell, C. Koncz, and A. Zilberstein. 1996. Mapping of the entomocidal fragment of Spodoptera-specific Bacillus thuringiensis toxin Cry1C. Mol. Gen. Genet. 253:11-19[CrossRef][Medline]. |
| 20. |
Towbin, H.,
T. Staehelin, and J. Gordon.
1979.
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.
Proc. Natl. Acad. Sci. USA
76:4350-4354 |
| 21. |
Wabiko, H., and E. Yasuda.
1995.
Bacillus thuringiensis protoxin: location of toxic border and requirement of non-toxic domain for high-level in vivo production of active toxin.
Microbiology
141:629-639 |
| 22. |
Wabiko, H.,
G. A. Held, and L. A. Bulla, Jr.
1985.
Only part of the protoxin gene of Bacillus thuringiensis subsp. berliner 1715 is necessary for insecticidal activity.
Appl. Environ. Microbiol.
49:706-708 |
| 23. |
Winder, W. R., and H. R. Whiteley.
1989.
Two highly related insecticidal crystal proteins of Bacillus thuringiensis subsp. kurstaki possess different host range specificities.
J. Bacteriol.
171:965-974 |
| 24. |
Wong, H. C., and S. Chang.
1986.
Identification of a positive retroregulator that stabilizes mRNAs in bacteria.
Proc. Natl. Acad. Sci. USA
83:3233-3237 |
| 25. |
Wu, D., and B. A. Federici.
1993.
A 20-kilodalton protein preserves cell viability and promotes CytA crystal formation during sporulation in Bacillus thuringiensis.
J. Bacteriol.
175:5276-5280 |
| 26. | Wu, D., and B. A. Federici. 1995. Improved production of the insecticidal CryIVD protein in Bacillus thuringiensis using cry1A(c) promoter to express the gene for an associated 20-kDa protein. Appl. Microbiol. Biotechnol. 42:697-702[CrossRef][Medline]. |
Applied and Environmental Microbiology, October 2000, p. 4449-4455, Vol. 66, No. 10
0099-2240/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Tan, Y., Spears, T., Bideshi, D. K., Johnson, J. J., Hice, R., Bigot, Y., Federici, B. A.
(2009). P64, a Novel Major Virion DNA-Binding Protein Potentially Involved in Condensing the Spodoptera frugiperda Ascovirus 1a Genome. J. Virol.
83: 2708-2714
[Abstract] [Full Text] -
Ito, T., Ikeya, T., Sahara, K., Bando, H., Asano, S.-i.
(2006). Cloning and Expression of Two Crystal Protein Genes, cry30Ba1 and cry44Aa1, Obtained from a Highly Mosquitocidal Strain, Bacillus thuringiensis subsp. entomocidus INA288. Appl. Environ. Microbiol.
72: 5673-5676
[Abstract] [Full Text] -
Bravo, A., Sanchez, J., Kouskoura, T., Crickmore, N.
(2002). N-terminal Activation Is an Essential Early Step in the Mechanism of Action of the Bacillus thuringiensis Cry1Ac Insecticidal Toxin. J. Biol. Chem.
277: 23985-23987
[Abstract] [Full Text] -
Shao, Z., Liu, Z., Yu, Z.
(2001). Effects of the 20-Kilodalton Helper Protein on Cry1Ac Production and Spore Formation in Bacillus thuringiensis. Appl. Environ. Microbiol.
67: 5362-5369
[Abstract] [Full Text]
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»